Analysis-Sanofi's new CEO needs to fix drug pipeline and navigate Trump [Yahoo! Finance Canada]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance Canada
REUTERS/Heiko Becker/File Photo By Bhanvi Satija and Maggie Fick 4 min read In this article By Bhanvi Satija and Maggie Fick LONDON, Feb 13 (Reuters) - Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors, accelerate the French company's stalled drug development pipeline and navigate vaccine scepticism in the United States under President Donald Trump. Investors, analysts and other people close to Garijo, who has headed ?Germany's Merck KGaA since 2021, told Reuters she was bold, detail-focused and got things done, but also that she had a mixed record on R&D and the share ?price had dropped during her tenure. Sanofi's stock, down 25% in the last year, fell 3.5% on Thursday after it said CEO Paul Hudson, 58, whose turnaround drive was stymied by a lack of new blockbuster drugs, would step down this ?month to be replaced by Garijo in April. "The CEO change at Sanofi is a sign that R&D transformation has failed or is happening too slow
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Prices, pipelines and patent cliffs: Inside pharma's big reset [CNBC]CNBC
- Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued [Seeking Alpha]Seeking Alpha
- Sanofi replaces CEO Paul Hudson with outgoing Merck KGaA head [Yahoo! Finance]Yahoo! Finance
- How founders can tap women investors as a competitive advantage in 2026 [Fortune]Fortune
- Does Sanofi's CEO Overhaul And Governance Shift Change The Bull Case For Sanofi (ENXTPA:SAN)? [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 2/12/26 - Form 6-K
- 2/11/26 - Form 13F-HR
- 2/10/26 - Form 6-K
- SNY's page on the SEC website